National Heart, Lung, and Blood Institute
Bethesda, Marylandnhlbi.nih.gov
Overview
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI stimulates basic discoveries about the causes of disease, enables the translation of basic discoveries into clinical practice, fosters training and mentoring of emerging scientists and physicians, and communicates research advances to the public.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Makani Science | May 2025 | Grant | Co-investor |
| Safi Biotherapeutics | Apr 2025 | Grant | Lead |
| IVOS Medical, Inc. | Jan 2025 | Grant | Co-investor |
| Dynocardia, Inc. | Oct 2024 | Grant | Lead |
| SafeBeat Rx | Sep 2024 | Grant | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
